{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T02:31:21Z","timestamp":1771641081455,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T00:00:00Z","timestamp":1649376000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ajoc.2022.101520","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T19:42:16Z","timestamp":1649965336000},"page":"101520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Regression of corneal opacity and neovascularization in Stevens-Johnson syndrome and Toxic Epidermal Necrolysis with the use of prosthetic replacement of the ocular surface ecosystem (PROSE) treatment"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3925-6279","authenticated-orcid":false,"given":"Jennifer","family":"Liao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6292-540X","authenticated-orcid":false,"given":"Bita","family":"Asghari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4023-0241","authenticated-orcid":false,"given":"Karen G.","family":"Carrasquillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajoc.2022.101520_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jtos.2015.10.002","article-title":"Stevens-Johnson Syndrome\/Toxic Epidermal Necrolysis - a comprehensive review and guide to therapy. I. Systemic disease","volume":"14","author":"Kohanim","year":"2015","journal-title":"Ocul Surf"},{"issue":"2","key":"10.1016\/j.ajoc.2022.101520_bib2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1542-0124(12)70273-2","article-title":"The ophthalmic management of acute Stevens-Johnson Syndrome","volume":"6","author":"Gregory","year":"2008","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajoc.2022.101520_bib3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/ICU.0b013e3283622718","article-title":"Current ophthalmologic treatment strategies for acute and chronic Stevens-Johnson Syndrome and toxic epidermal necrolysis","volume":"24","author":"Ciralsky","year":"2013","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ajoc.2022.101520_bib6","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.autrev.2008.06.004","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"7","author":"Borchers","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.ajoc.2022.101520_bib4","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jtos.2016.02.001","article-title":"Acute and chronic ophthalmic involvement in Stevens-Johnson Syndrome\/Toxic Epidermal Necrolysis \u2013 a comprehensive review and guide to therapy. II. Ophthalmic disease","volume":"14","author":"Kohanim","year":"2016","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajoc.2022.101520_bib5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1081-1206(10)61112-X","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature","volume":"94","author":"Letko","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.ajoc.2022.101520_bib7","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/BCR.0b013e3181848bb1","article-title":"Toxic epidermal necrolysis clinical guidelines","volume":"29","author":"Endorf","year":"2008","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.ajoc.2022.101520_bib10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/ICO.0b013e31802eb264","article-title":"Erythema multiforme, Stevens- Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management","volume":"26","author":"Chang","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.ajoc.2022.101520_bib11","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1136\/bjo.2006.109124","article-title":"The natural history of Stevens-Johnson syndrome: patterns of chronic ocular disease and the role systemic immunosuppressive therapy","volume":"91","author":"De Rojas","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajoc.2022.101520_bib12","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/sj.eye.6701653","article-title":"Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series","volume":"19","author":"Yip","year":"2005","journal-title":"Eye"},{"key":"10.1016\/j.ajoc.2022.101520_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/01.BCR.0000150215.78220.79","article-title":"Late outcomes in adult survivors of toxic epidermal necrolysis after treatment a burn center","volume":"26","author":"Haber","year":"2005","journal-title":"J Burn Care Rehabil"},{"key":"10.1016\/j.ajoc.2022.101520_bib14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ajo.2019.07.006","article-title":"Long-term effect of a treatment protocol for acute ocular involvement in Stevens-Johnson Syndrome\/Toxic Epidermal Necrolysis","volume":"208","author":"Shanbhag","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoc.2022.101520_bib9","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0161-6420(95)30811-1","article-title":"Analysis of the acute ophthalmic manifestations of the erythema multiforme\/Stevens-Johnson syndrome\/toxic epidermal necrolysis disease spectrum","volume":"102","author":"Power","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2022.101520_bib15","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ophtha.2014.08.015","article-title":"Prosthetic replacement of the ocular surface ecosystem as treatment for ocular surface disease in patients with a history of Stevens-Johnson Syndrome\/Toxic Epidermal Necrolysis","volume":"122","author":"Papakostas","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2022.101520_bib8","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.ajo.2009.07.006","article-title":"Vision-related function after scleral lens fitting in ocular complications of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis","volume":"148","author":"Tougeron-Brousseau","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoc.2022.101520_bib18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ajo.2012.09.033","article-title":"PROSE therapy used to minimize corneal trauma in patients with corneal epithelial defects","volume":"155","author":"Ling","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajoc.2022.101520_bib16","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/01.ICL.0000152492.98553.8D","article-title":"Fluid-ventilated, gas-permeable scleral contact lens is an effective option of managing severe ocular surface disease and many corneal disorders that would otherwise require penetrating keratoplasty","volume":"31","author":"Rosenthal","year":"2005","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.ajoc.2022.101520_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ajo.2014.03.012","article-title":"Prosthetic replacement of the ocular surface ecosystem scleral lens therapy for patients with ocular symptoms of chronic Stevens-Johnson Syndrome","volume":"158","author":"Heur","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoc.2022.101520_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0002-9394(00)00378-0","article-title":"Gas-permeable scleral contact lens therapy in ocular surface disease","volume":"1301","author":"Romero-Rangel","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoc.2022.101520_bib20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.clae.2015.08.003","article-title":"Complications and fitting challenges associated with scleral contact lenses: a review","volume":"39","author":"Walker","year":"2015","journal-title":"Contact Lens Anterior Eye"},{"key":"10.1016\/j.ajoc.2022.101520_bib30","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/ICL.0b013e3182657da5","article-title":"The effect of optic asphericity on visual rehabilitation of corneal ectasia with a prosthetic device","volume":"38","author":"Hussoin","year":"2012","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.ajoc.2022.101520_bib25","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/ICO.0b013e318155743d","article-title":"Boston Scleral Lens Prosthetic Device for treatment of severe dry eye in chronic graft-versus-host disease","volume":"26","author":"Jacobs","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.ajoc.2022.101520_bib24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ajo.2009.07.037","article-title":"Clinical benefits of the Boston ocular surface prosthesis","volume":"149","author":"Stason","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoc.2022.101520_bib27","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ajo.2016.06.039","article-title":"Stevens-Johnson syndrome and corneal ectasia: management and a case for association","volume":"169","author":"Saeed","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoc.2022.101520_bib28","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jtos.2019.07.006","article-title":"Corneal higher-order aberrations in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"17","author":"Ibrahim","year":"2019","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajoc.2022.101520_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2018.05.030","article-title":"Corneal ectasia in Stevens-Johnson Syndrome: a sequela of chronic disease","volume":"193","author":"Maharana","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2022.101520_bib31","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/opo.12908","article-title":"Fluid reservoir thickness and aberration relationship in keratoconic eyes with scleral lenses","volume":"42","author":"Balakrishnan","year":"2022","journal-title":"Ophthalmic Physiol Opt"},{"issue":"5","key":"10.1016\/j.ajoc.2022.101520_bib32","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.ajo.2014.07.012","article-title":"Tear exchangeable limbal rigid contact lens for ocular sequelae resulting from Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis","volume":"158","author":"Sotozono","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajoc.2022.101520_bib33","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.ophtha.2006.10.029","article-title":"New grading system for the evaluation of chronic ocular manifestations in patients with Stevens\u2013Johnson syndrome","volume":"14","author":"Sotozono","year":"2007","journal-title":"Ophthalmol Times"},{"key":"10.1016\/j.ajoc.2022.101520_bib21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1542-0124(12)70051-4","article-title":"Therapeutic and ocular surface indications for scleral contact lenses","volume":"5","author":"Pullum","year":"2007","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.ajoc.2022.101520_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.22336\/rjo.2019.4","article-title":"Corneal neovascularization: updates on pathophysiology, investigations & management","volume":"63","author":"Sharif","year":"2019","journal-title":"Rom. J. Ophthalmol."},{"key":"10.1016\/j.ajoc.2022.101520_bib26","first-page":"108","article-title":"Improvement of chronic corneal opacity in ocular surface disease with prosthetic replacement of the ocular surface ecosystem (PROSE) treatment","volume":"10","author":"Cressey","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajoc.2022.101520_bib35","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1444-0938.2011.00618.x","article-title":"Limbal stem cell disease: management with scleral lenses","volume":"94","author":"Shornack","year":"2011","journal-title":"Clin Exp Optom"},{"key":"10.1016\/j.ajoc.2022.101520_bib22","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00006324-200110000-00013","article-title":"The role of fenestrations and channels on the transverse motion of a soft contact lens","volume":"78","author":"Chauhan","year":"2001","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.ajoc.2022.101520_bib23","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1001\/archderm.1990.01670320127028","article-title":"Incidence of toxic epidermalnecrolysis in Italy","volume":"126","author":"Naldi","year":"1990","journal-title":"Arch Dermatol"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993622002663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993622002663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:58:50Z","timestamp":1762527530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993622002663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":35,"alternative-id":["S2451993622002663"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2022.101520","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regression of corneal opacity and neovascularization in Stevens-Johnson syndrome and Toxic Epidermal Necrolysis with the use of prosthetic replacement of the ocular surface ecosystem (PROSE) treatment","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2022.101520","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101520"}}